Evidence map›Paper›PMID 38114471›Full record

ArticleNature communications2023

NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62.

Nikolas Furthmann, Verian Bader, Lena Angersbach, Alina Blusch, Simran Goel, Ana Sánchez-Vicente, Laura J Krause, Sarah A Chaban, Prerna Grover, Victoria A Trinkaus and 21 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Targeting neuroinflammation in neurodegenerative disorders: the emerging potential of semaglutide.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  6. Review
  7. Review
  8. The deubiquitinase OTULIN regulates tau expression and RNA metabolism in neurons.Genomic psychiatry : advancing science from genes to society · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Topological confinement by a membrane anchor suppresses phase separation into protein aggregates: Implications for prion diseases.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 13 institutions in 3 countries.

Nikolas FurthmannDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.ORCID 0000-0002-6643-7470
Verian BaderDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.ORCID 0000-0001-5260-4728
Lena AngersbachDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.
Alina BluschDepartment of Neurology, St Josef Hospital, Ruhr University Bochum, 44791, Bochum, Germany.
Simran GoelDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.
Ana Sánchez-VicenteDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.
Laura J KrauseDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.ORCID 0000-0002-2086-3757
Sarah A ChabanDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.ORCID 0009-0000-1543-4512
Prerna GroverDepartment Biochemistry of Neurodegenerative Diseases, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.ORCID 0000-0001-5132-0635
Victoria A TrinkausDepartment of Cellular Biochemistry, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.
Eva M van WellDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.
Maximilian JaugstetterAnalytical Chemistry II, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, 44801, Bochum, Germany.
Kristina TschulikCluster of Excellence RESOLV, 44801, Bochum, Germany.ORCID 0000-0001-7637-4082
Rune Busk DamgaardDepartment of Biotechnology and Biomedicine, Technical University of Denmark, 2800, Kongens Lyngby, Denmark.ORCID 0000-0002-1709-6534
Carsten SaftDepartment of Neurology, St Josef Hospital, Ruhr University Bochum, 44791, Bochum, Germany.
Gisa EllrichmannDepartment of Neurology, St Josef Hospital, Ruhr University Bochum, 44791, Bochum, Germany.
Ralf GoldDepartment of Neurology, St Josef Hospital, Ruhr University Bochum, 44791, Bochum, Germany.
Arend KochCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, 10117, Berlin, Germany.
Benjamin EnglertCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Neuropathology, Charitéplatz 1, 10117, Berlin, Germany.ORCID 0000-0002-1769-5393
Ana WestenbergerInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Christine KleinInstitute of Neurogenetics, University of Lübeck, Lübeck, Germany.
Lisa JungbluthErnst-Ruska Centre for Microscopy and Spectroscopy with Electrons (ER-C-3/Structural Biology), Forschungszentrum Jülich, Jülich, Germany.ORCID 0000-0002-5295-0521
Carsten SachseErnst-Ruska Centre for Microscopy and Spectroscopy with Electrons (ER-C-3/Structural Biology), Forschungszentrum Jülich, Jülich, Germany.ORCID 0000-0002-1168-5143
Christian BehrendsMunich Cluster for Systems Neurology, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID 0000-0002-9184-7607
Markus GlatzelInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20251, Hamburg, Germany.ORCID 0000-0002-7720-8817
F Ulrich HartlDepartment of Cellular Biochemistry, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.ORCID 0000-0002-7941-135X
Ken NakamuraGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA, USA.
Chadwick W ChristineDepartment of Neurology, University of California, San Francisco, CA, USA.ORCID 0000-0003-4166-9432
Eric J HuangDepartment of Neurology, University of California, San Francisco, CA, USA.ORCID 0000-0002-5381-3801
Jörg TatzeltDepartment Biochemistry of Neurodegenerative Diseases, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany.
Konstanze F WinklhoferDepartment Molecular Cell Biology, Institute of Biochemistry and Pathobiochemistry, Ruhr University Bochum, 44801, Bochum, Germany. konstanze.winklhofer@rub.de.ORCID 0000-0002-7256-8231
Ruhr University Bochum · DESt. Josef-Hospital · DEForschungszentrum Jülich · DEHumboldt-Universität zu Berlin · DEMunich Cluster for Systems Neurology · DEUniversity of California, San Francisco · USUniversity of Lübeck · DEGladstone Institutes · USMax Planck Institute of Biochemistry · DETechnical University of Denmark · DKUniversität Hamburg · DEUniversity Hospitals of the Ruhr-University of Bochum · DEWitten/Herdecke University · DE

Funding

Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human CellsR01AG065428 · NIA · J. DAVID GLADSTONE INSTITUTES · PI NAKAMURA, KEN · 2020 to 2024
$3.7M
NIA NIH HHS R01 AG065428
6 · The paper itself

Abstract

NEMO is a ubiquitin-binding protein which regulates canonical NF-κB pathway activation in innate immune signaling, cell death regulation and host-pathogen interactions. Here we identify an NF-κB-independent function of NEMO in proteostasis regulation by promoting autophagosomal clearance of protein aggregates. NEMO-deficient cells accumulate misfolded proteins upon proteotoxic stress and are vulnerable to proteostasis challenges. Moreover, a patient with a mutation in the NEMO-encoding IKBKG gene resulting in defective binding of NEMO to linear ubiquitin chains, developed a widespread mixed brain proteinopathy, including α-synuclein, tau and TDP-43 pathology. NEMO amplifies linear ubiquitylation at α-synuclein aggregates and promotes the local concentration of p62 into foci. In vitro, NEMO lowers the threshold concentrations required for ubiquitin-dependent phase transition of p62. In summary, NEMO reshapes the aggregate surface for efficient autophagosomal clearance by providing a mobile phase at the aggregate interphase favoring co-condensation with p62.

Indexed as

I-kappa B KinaseNF-kappa Balpha-SynucleinAutophagyHumansUbiquitinalpha-SynucleinI-kappa B KinaseIKBKG protein, humanNF-kappa BUbiquitin

Identifiers

PMID38114471
PMCPMC10730909
OpenAlexW4389951506

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.